Literature DB >> 5789805

The interaction between monoamine oxidase inhibitors and narcotic analgesics in mice.

K J Rogers, J A Thornton.   

Abstract

1. The administration of either iproniazid or tranylcypromine to mice potentiates the acute toxicity of pethidine, morphine, pentazocine and phenazocine.2. Blood levels of pentazocine in mice pretreated with tranylcypromine do not differ from the levels in animals not receiving the monoamine oxidase (MAO) inhibitor.3. There is no correlation between changes in brain and liver MAO activity and the increased pethidine toxicity.4. A comparison is made between the change in pethidine toxicity and the changes in the concentration of cerebral noradrenaline, dopamine and 5-hydroxytryptamine following the injection of tranylcypromine.5. It is concluded that the increased toxicity of potent analgesics in combination with MAO inhibitors is not due to a decelerated metabolism of the analgesic drug, but is related to an increased concentration of cerebral 5-hydroxytryptamine. A critical level of this monoamine, in the brain, may be necessary before the drug interaction will take place.

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 5789805      PMCID: PMC1703598          DOI: 10.1111/j.1476-5381.1969.tb08003.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  26 in total

1.  A differential action of reserpine on brain dopamine stores in rabbit.

Authors:  E COSTA; G L GESSA; R KUNTZMAN; B B BRODIE
Journal:  Life Sci (1962)       Date:  1962-11

2.  RELEASE OF THYROIDAL SEROTONIN BY RESERPINE, METHYLDOPA AND GUANETHIDINE.

Authors:  R D MAGUS; F W KRAUSE; B E RIEDEL
Journal:  Biochem Pharmacol       Date:  1964-01       Impact factor: 5.858

3.  EFFECT OF DRUGS ON THE UPTAKE, RELEASE, AND METABOLISM OF H3-NOREPINEPHRINE IN THE RAT BRAIN.

Authors:  J GLOWINSKI; J AXELROD
Journal:  J Pharmacol Exp Ther       Date:  1965-07       Impact factor: 4.030

4.  Comparison of the effects of single doses of morphine and thebaine on body temperature, activity, and brain and heart levels of catecholamines and serotonin.

Authors:  J W SLOAN; J W BROOKS; A J EISENMAN; W R MARTIN
Journal:  Psychopharmacologia       Date:  1962-10-05

5.  An effect of monoamine oxidase inhibitors on brain serotonin of mice in addition to that resulting from inhibition of monoamine oxidase.

Authors:  B DUBNICK; G A LEESON; G E PHILLIPS
Journal:  J Neurochem       Date:  1962 May-Jun       Impact factor: 5.372

6.  Lack of relationship between inhibition of monoamine oxidase and potentiation of hexobarbital hypnosis.

Authors:  M J LAROCHE; B B BRODIE
Journal:  J Pharmacol Exp Ther       Date:  1960-10       Impact factor: 4.030

7.  Toxic effects of iproniazid in a patient with angina.

Authors:  C PAPP; S BENAIM
Journal:  Br Med J       Date:  1958-11-01

8.  Identification and assay of serotonin in brain.

Authors:  D F BOGDANSKI; A PLETSCHER; B B BRODIE; S UNDENFRIEND
Journal:  J Pharmacol Exp Ther       Date:  1956-05       Impact factor: 4.030

9.  Inhibition of drug metabolism. I. Kinetics of the inhibition of the N-demethylation of ethylmorphine by 2-diethylaminoethyl 2,2-diphenylvalerate HC1 (SKF 525-A) and related compounds.

Authors:  M W Anders; G J Mannering
Journal:  Mol Pharmacol       Date:  1966-07       Impact factor: 4.436

10.  The in vitro inhibition of the N-demethylation of pethidine by phenelzine (Phenethylhydrazine).

Authors:  B Clark
Journal:  Biochem Pharmacol       Date:  1967-12       Impact factor: 5.858

View more
  14 in total

1.  The production of morphine tolerance and physical dependence by the oral route in the rat. A comparative study.

Authors:  V O Fuentes; W B Hunt; J Crossland
Journal:  Psychopharmacology (Berl)       Date:  1978-09-15       Impact factor: 4.530

Review 2.  Clinical features, pathogenesis and management of drug-induced seizures.

Authors:  G Zaccara; G C Muscas; A Messori
Journal:  Drug Saf       Date:  1990 Mar-Apr       Impact factor: 5.606

Review 3.  Monoamine oxidase inhibitors revisited.

Authors:  D G Wells; A R Bjorksten
Journal:  Can J Anaesth       Date:  1989-01       Impact factor: 5.063

Review 4.  Release from brain tissue of compounds with possible transmitter function: interaction of drugs with these substances.

Authors:  M Vogt
Journal:  Br J Pharmacol       Date:  1969-10       Impact factor: 8.739

5.  Role of brain monoamines in the fatal hyperthermia induced by pethidine or imipramine in rabbits pretreated with a monoamine oxidase inhibitor.

Authors:  S N Gong; K J Rogers
Journal:  Br J Pharmacol       Date:  1973-05       Impact factor: 8.739

6.  Conscious-sedation in a patient on combined tranylcypromine and lithium therapy--a case report.

Authors:  J D Freilich; C R Bennett
Journal:  Anesth Prog       Date:  1983 May-Jun

7.  Effect of nonselective and selective inhibitors of monoamine oxidases A and B on pethidine toxicity in mice.

Authors:  R Boden; R Botting; P Coulson; G Spanswick
Journal:  Br J Pharmacol       Date:  1984-05       Impact factor: 8.739

Review 8.  Clinical pharmacokinetics of pethidine.

Authors:  L E Mather; P J Meffin
Journal:  Clin Pharmacokinet       Date:  1978 Sep-Oct       Impact factor: 6.447

Review 9.  Pharmacokinetic drug interactions in anaesthetic practice.

Authors:  M Wood
Journal:  Clin Pharmacokinet       Date:  1991-10       Impact factor: 6.447

Review 10.  The serotonin syndrome. Implicated drugs, pathophysiology and management.

Authors:  K A Sporer
Journal:  Drug Saf       Date:  1995-08       Impact factor: 5.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.